Evidence map›Paper›PMID 18678614›Full record

ArticleDiabetes2008

Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.

Marju Orho-Melander, Olle Melander, Candace Guiducci, Pablo Perez-Martinez, Dolores Corella, Charlotta Roos, Ryan Tewhey, Mark J Rieder, Jennifer Hall, Goncalo Abecasis and 31 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Diabetes, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01231958 (The Boston Puerto Rican Health Study), which is not on this map. Cited by 168 papers, 17 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
168citing papers in PubMed, 17 pooled it
29.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01231958 completednot on this map

The Boston Puerto Rican Health Study: Center for Population Health and Health Disparities

TypeobservationalSponsorUniversity of Massachusetts, LowellRan2004 to 2017Enrolled1,650ConditionsCardiovascular Risk FactorArmsThe Heart Healthy Initiative for Hispanic Adults (HIP)
3 · Its place in the literature

Who cites it

168 citing papers in PubMed, 17 syntheses or guidelines pooled it, 318 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Trial
  19. Trial
  20. Trial

108 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 13 institutions in 5 countries.

Marju Orho-MelanderDepartment of Clinical Sciences, University Hospital Malmö, Clinical Research Center, Lund University, Malmö, Sweden. marju.orho-melander@med.lu.se
Olle Melander
Candace Guiducci
Pablo Perez-Martinez
Dolores Corella
Charlotta Roos
Ryan Tewhey
Mark J Rieder
Jennifer Hall
Goncalo Abecasis
E Shyong Tai
Cullan Welch
Donna K Arnett
Valeriya Lyssenko
Eero Lindholm
Richa Saxena
Paul I W de Bakker
Noel Burtt
Benjamin F Voight
Joel N Hirschhorn
Katherine L Tucker
Thomas Hedner
Tiinamaija Tuomi
Bo Isomaa
Karl-Fredrik Eriksson
Marja-Riitta Taskinen
Björn Wahlstrand
Thomas E Hughes
Laurence D Parnell
Chao-Qiang Lai
Göran Berglund
Leena Peltonen
Erkki Vartiainen
Pekka Jousilahti
Aki S Havulinna
Veikko Salomaa
Peter Nilsson
Leif Groop
David Altshuler
Jose M Ordovas
Sekar Kathiresan
Broad Institute · USLund University · SETufts University · USUniversity of Helsinki · FIUniversity of Minnesota · USBoston Biomedical Research Institute · USFolkhälsans Forskningscentrum · FIInstitute for Molecular Medicine Finland · FISingapore General Hospital · SGUniversitat de València · ESUniversity of Alabama at Birmingham · USUniversity of Michigan · USUniversity of Washington · US

Funding

TOXIC DRUG INTERACTIONS WITH VALPROIC ACIDP01GM032165 · NIGMS · UNIVERSITY OF WASHINGTON · PI RETTIE, ALLAN EDWARD · 1985 to 2012
$18.3M
Genetic and Environmental Determinants of TriglyceridesU01HL072524 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ARNETT, DONNA K · 2002 to 2008
$11.9M
Center for Research/Nutrition &Health among the ElderlyP01AG023394 · NIA · TUFTS UNIVERSITY BOSTON · PI TUCKER, KATHERINE L · 2003 to 2007
$8.1M
GENE/DIET EFFECTS ON PLASMA LIPOPROTEIN LEVELSR01HL054776 · NHLBI · TUFTS UNIVERSITY BOSTON · PI ORDOVAS, JOSE M. · 1996 to 2010
$2.6M
Genetic Factors Influencing Warfarin DoseR01NS053646 · NINDS · UNIVERSITY OF WASHINGTON · PI RIEDER, MARK J · 2006 to 2008
$1.1M
Osteoprotegerin Pathway: Relations of Genes & Biomarkers to CVD in the CommunityK23HL083102 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KATHIRESAN, SEKAR · 2006 to 2008
$482k
NHLBI NIH HHS HL-54776NHLBI NIH HHS K23 HL083102NHLBI NIH HHS K23-HL-083102NHLBI NIH HHS R01 HL054776NHLBI NIH HHS U01 HL072524NHLBI NIH HHS U01-HL-72524NIA NIH HHS P01 AG023394NIA NIH HHS P01-AG-023394-03NIGMS NIH HHS P01 GM032165NIGMS NIH HHS P01-GM-32165NINDS NIH HHS R01 NS053646NINDS NIH HHS R01-NS-053646PHS HHS 53-K06-5-10
6 · The paper itself

Abstract

objectiveUsing the genome-wide association approach, we recently identified the glucokinase regulatory protein gene (GCKR, rs780094) region as a novel quantitative trait locus for plasma triglyceride concentration in Europeans. Here, we sought to study the association of GCKR variants with metabolic phenotypes, including measures of glucose homeostasis, to evaluate the GCKR locus in samples of non-European ancestry and to fine- map across the associated genomic interval. RESEARCH DESIGN AND

methodsWe performed association studies in 12 independent cohorts comprising >45,000 individuals representing several ancestral groups (whites from Northern and Southern Europe, whites from the U.S., African Americans from the U.S., Hispanics of Caribbean origin, and Chinese, Malays, and Asian Indians from Singapore). We conducted genetic fine-mapping across the approximately 417-kb region of linkage disequilibrium spanning GCKR and 16 other genes on chromosome 2p23 by imputing untyped HapMap single nucleotide polymorphisms (SNPs) and genotyping 104 SNPs across the associated genomic interval.

resultsWe provide comprehensive evidence that GCKR rs780094 is associated with opposite effects on fasting plasma triglyceride (P(meta) = 3 x 10(-56)) and glucose (P(meta) = 1 x 10(-13)) concentrations. In addition, we confirmed recent reports that the same SNP is associated with C-reactive protein (CRP) level (P = 5 x 10(-5)). Both fine-mapping approaches revealed a common missense GCKR variant (rs1260326, Pro446Leu, 34% frequency, r(2) = 0.93 with rs780094) as the strongest association signal in the region.

conclusionsThese findings point to a molecular mechanism in humans by which higher triglycerides and CRP can be coupled with lower plasma glucose concentrations and position GCKR in central pathways regulating both hepatic triglyceride and glucose metabolism.

Indexed as

Mutation, MissenseAdaptor Proteins, Signal TransducingAdultAgedAnalysis of VarianceBlood GlucoseC-Reactive ProteinFastingFemaleGene FrequencyGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotideTriglyceridesAdaptor Proteins, Signal TransducingBlood GlucoseC-Reactive ProteinGCKR protein, humanTriglycerides

Identifiers

PMID18678614
PMCPMC2570409
OpenAlexW2119913660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.